Miriam Koopman

Full Professor

Strategic program(s):

Contact

mkoopma6@umcutrecht.nl

Pure profile

Research groups

Medical oncology colorectal cancer group

Research aim

To improve outcomes and quality of life for all patients with colorectal and anal cancer by developing and validating biomarkers, enhancing therapeutic strategies, refining patient selection, and studying real life treatment outcomes.

Go to group

Recent publications

All publications

The nationwide Dietary Intake after Diagnosis and Colorectal Cancer Outcomes (PLCRC-PROTECT) cohort Jeroen W.G. Derksen, Karel C. Smit, Irene W.F. Hoeven, Femke P.C. Sijtsma, Miriam Koopman, Anne M. May
Cancer Epidemiology, 2025, vol. 94

Reply - Letter to the editor entitled “Letter to editor regarding Dietary and lifestyle inflammation scores in relation to colorectal cancer recurrence and all-cause mortality Evertine Wesselink, Hendriek C. Boshuizen, Anne Sophie van Lanen, Dieuwertje E. Kok, Jeroen W.G. Derksen, Karel C. Smit, Johannes H.W. de Wilt, Miriam Koopman, Anne M. May, Ellen Kampman, Fränzel J.B. van Duijnhoven
Clinical Nutrition, 2025, vol. 44, p.5-6

Reply to Letter to the Editor “Optimising Treatment Strategies in Metastatic Colorectal Cancer J. H.W. de Wilt, D. E.W. van der Kruijssen, M. Koopman
Annals of Oncology, 2024, vol. 36, p.122-124

Reply - Letter to the editor entitled “Letter to editor - Dietary and lifestyle inflammation scores in relation to colorectal cancer recurrence and all-cause mortality Evertine Wesselink, Hendriek C. Boshuizen, Anne Sophie van Lanen, Dieuwertje E. Kok, Jeroen W.G. Derksen, Karel C. Smit, Johannes H.W. de Wilt, Miriam Koopman, Anne M. May, Ellen Kampman, Fränzel J.B. van Duijnhoven
Clinical Nutrition, 2024, vol. 43, p.341

Development of a prediction model for clinically-relevant fatigue Dhirendra Adiprakoso, Dimitris Katsimpokis, Simone Oerlemans, Nicole P.M. Ezendam, Marissa C. van Maaren, Janine A. van Til, Thijs G.W. van der Heijden, Floortje Mols, Katja K.H. Aben, Geraldine R. Vink, Miriam Koopman, Lonneke V. van de Poll-Franse, Belle H. de Rooij
Quality of Life Research, 2024, vol. 34, p.231-245

Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases K. Zwart, M. N.G.J.A. Braat, F. H. van der Baan, A. M. May, J. M.L. Roodhart, D. Al-Toma, J. M.M.B. Otten, M. Los, T. Oostergo, R. J.A. Fijneman, J. M. van Dodewaard-de Jong, C. J.A. Punt, G. Meijer, J. J.W. Lagendijk, M. Koopman, M. Intven, G. M. Bol
Clinical and translational radiation oncology, 2024, vol. 49, p.1-5

External positions

Member of the Quality Committee - lid - NVMO

Board member - lid - Onconext

Member of the data science and cohorts boards - lid - UMC Utrecht

Vice-chair/secretary of the Dutch Colorectal Cancer Group - vicevoorzitter/secretaris - DCCG

Chair of newly established RWD and digital health working group - voorzitter - ESMO

Faculty member for the Gastro-Intestinal Tumours-colorectal - lid - ESMO

Chair of expertise group colorectal Cancer 'uitkomstgerichte zorg' - voorzitter - FMS

Chair of workpackage 'well defined patient cohorts' of the national growth fund grant application - voorzitter - Oncode accelerator

Leading member of the Health sciences group - lid - NWO-GWI

Expert member of committee 'regie op registers dure geneesmiddelen' - lid - Zorginstituut NL

CRC expert on platform for answering online CRC questions - expert op basis van vraag/antwoord - Kanker.nl

Participant in the international collaboration of ARCAD - Participant, integrating patient-level data - ARCAD

founder and PI of the Dutch Prospective CRC cohort study - founder and PI - PLCRC